News | April 10, 2024
President Murmu to inaugurate homeopathic symposium on World Homoeopathy Day 2024
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
Keynote -564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy alone
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Subscribe To Our Newsletter & Stay Updated
